US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IN8bio, Inc.

1.28

+0.07005.79%

Post-market: 1.280.00000.00%19:30 EDT

Volume:105.89K

Turnover:131.95K

Market Cap:12.60M

PE:-0.68

High:1.30

Open:1.23

Low:1.18

Close:1.21

52wk High:2.73

52wk Low:0.8800

Shares:9.85M

Float Shares:6.26M

Volume Ratio:2.26

T/O Rate:1.69%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8935

EPS(LYR):-4.4441

ROE:-111.11%

ROA:-58.37%

PB:0.69

PE(LYR):-0.29

Loading ...

Overview Company News Filings

Mizuho Securities Reaffirms Their Buy Rating on IN8bio (INAB)

IN8bio Grants New Hire Stock Option for 4,000 Shares Under Inducement Plan

IN8bio Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Analysts Offer Insights on Healthcare Companies: IN8bio (INAB), Lineage Therap (LCTX) and BioLife Solutions (BLFS)

IN8bio Q2 EPS $(0.25) Beats $(0.37) Estimate

Benzinga Earnings

IN8bio, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Biopharma Firm IN8bio's Q2 Net Loss Narrows as Expenses Decline

Press Release: IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights

IN8bio Inc Expected to Post a Loss of 37 Cents a Share - Earnings Preview

IN8bio therapy doubles progression free survival in brain cancer trial

In8bio Says JCO Publication Shows Inb-200 Trial Doubles Progression-free Survival in Repeat-dose Glioblastoma Patients

IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma

Analysts Are Bullish on Top Healthcare Stocks: Corvus Pharmaceuticals (CRVS), IN8bio (INAB)

IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies

IN8bio posts corporate deck highlighting gamma-delta T-cell therapy platform for autoimmune disease, cancer

IN8bio announces updated INB-200, INB-400 study data

IN8bio says DeltEx DRI glioblastoma trial shows median overall survival exceeds 19.5 months at ASCO 2026

BRIEF-IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering

IN8bio - Enters Capital on Demand Sales Agreement With Jonestrading for Atm Offering - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/INAB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INAB\",,,,,undefined,":{"symbol":"INAB","market":"US","secType":"STK","nameCN":"IN8bio, Inc.","latestPrice":1.28,"timestamp":1787342400000,"preClose":1.21,"halted":0,"volume":105890,"hourTrading":{"tag":"盘后","latestPrice":1.28,"preClose":1.28,"latestTime":"19:30 EDT","volume":24425,"amount":31462.2475,"timestamp":1787355006070,"change":0,"changeRate":0,"amplitude":0.015625},"delay":0,"changeRate":0.05785123966942154,"floatShares":6261300,"shares":9847100,"eps":-1.8935153,"marketStatus":"Market Closed","change":0.07,"latestTime":"08-21 16:00:00 EDT","open":1.23,"high":1.3,"low":1.18,"amount":131948.491278,"amplitude":0.099174,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.8935153,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1605157200000,"exchange":"NASDAQ","adjPreClose":1.21,"preHourTrading":{"tag":"盘前","latestPrice":1.17,"preClose":1.21,"latestTime":"04:00 EDT","volume":95,"amount":111.14999999999999,"timestamp":1787299212676,"change":-0.04,"changeRate":-0.033058,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.28,"preClose":1.28,"latestTime":"19:30 EDT","volume":24425,"amount":31462.2475,"timestamp":1787355006070,"change":0,"changeRate":0,"amplitude":0.015625},"volumeRatio":2.256897076079114},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INAB\",,,,,undefined,":{"symbol":"INAB","floatShares":6261300,"roa":"-58.37%","roe":"-111.11%","lyrEps":-4.444111,"volumeRatio":2.256897076079114,"shares":9847100,"dividePrice":0,"high":1.3,"amplitude":0.099174,"preClose":1.21,"low":1.18,"week52Low":0.88,"pbRate":"0.69","week52High":2.73,"institutionHeld":0,"latestPrice":1.28,"eps":-1.8935153,"divideRate":0,"volume":105890,"delay":0,"ttmEps":-1.8935153,"open":1.23,"prevYearClose":2.34,"prevWeekClose":1.1,"prevMonthClose":1.035,"prevQuarterClose":1.41,"fiveDayClose":1.1,"twentyDayClose":1.2,"sixtyDayClose":1.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"INAB","fiscalQuarterEnding":"2026/06","expectedEps":-0.61,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.25},{"market":"US","date":"2026-05-07","symbol":"INAB","fiscalQuarterEnding":"2026/03","expectedEps":-0.59,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2026-03-12","symbol":"INAB","fiscalQuarterEnding":"2025/12","expectedEps":-0.18,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2025-11-06","symbol":"INAB","fiscalQuarterEnding":"2025/09","expectedEps":-1.2,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.85},{"market":"US","date":"2025-08-07","symbol":"INAB","fiscalQuarterEnding":"2025/06","expectedEps":-1.5,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-1.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INAB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1768449600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INAB","date":"2026-08-21","current":-0.675991,"percent":0.738812,"low":-18.431444,"twenty":-2.436177,"median":-1.166577,"eighty":-0.515939,"high":-0.259966,"avg":-2.381815,"sd":3.394644,"marketCap":11928643},"quantilePoints":[{"date":"2021-08-27","current":-14.936176,"twenty":-60.555129,"median":-60.555129,"eighty":-22.35346,"marketCap":137845964},{"date":"2021-09-03","current":-16.907344,"twenty":-60.555129,"median":-60.555129,"eighty":-20.215656,"marketCap":156037880},{"date":"2021-09-10","current":-17.727589,"twenty":-60.555129,"median":-60.555129,"eighty":-20.040893,"marketCap":166727976},{"date":"2021-09-17","current":-13.958732,"twenty":-60.555129,"median":-60.555129,"eighty":-19.085791,"marketCap":131281871},{"date":"2021-09-24","current":-15.155194,"twenty":-60.555129,"median":-60.555129,"eighty":-18.138817,"marketCap":142534602},{"date":"2021-10-01","current":-14.736432,"twenty":-60.555129,"median":-60.555129,"eighty":-17.663778,"marketCap":138596146},{"date":"2021-10-08","current":-12.881915,"twenty":-60.555129,"median":-60.555129,"eighty":-16.140999,"marketCap":121154412},{"date":"2021-10-15","current":-11.984369,"twenty":-60.555129,"median":-60.555129,"eighty":-15.651486,"marketCap":112712988},{"date":"2021-10-22","current":-13.280736,"twenty":-60.555129,"median":-60.555129,"eighty":-14.97998,"marketCap":124905322},{"date":"2021-10-29","current":-15.135253,"twenty":-60.555129,"median":-60.555129,"eighty":-14.672621,"marketCap":142347057},{"date":"2021-11-05","current":-14.955784,"twenty":-60.555129,"median":-60.555129,"eighty":-14.748397,"marketCap":140659147},{"date":"2021-11-12","current":-14.224101,"twenty":-60.555129,"median":-60.555129,"eighty":-14.60881,"marketCap":158100881},{"date":"2021-11-19","current":-11.473771,"twenty":-60.555129,"median":-22.35346,"eighty":-14.426892,"marketCap":127530960},{"date":"2021-11-26","current":-11.389405,"twenty":-60.555129,"median":-22.35346,"eighty":-13.958732,"marketCap":126593232},{"date":"2021-12-03","current":-9.448987,"twenty":-60.555129,"median":-20.321327,"eighty":-13.818503,"marketCap":105025496},{"date":"2021-12-10","current":-11.170053,"twenty":-60.555129,"median":-20.199399,"eighty":-13.58292,"marketCap":124155140},{"date":"2021-12-17","current":-10.36014,"twenty":-60.555129,"median":-20.04699,"eighty":-13.380441,"marketCap":115152955},{"date":"2021-12-23","current":-10.377013,"twenty":-60.555129,"median":-19.843776,"eighty":-13.252819,"marketCap":115340500},{"date":"2021-12-31","current":-7.407331,"twenty":-60.555129,"median":-19.000441,"eighty":-12.570834,"marketCap":82332487},{"date":"2022-01-07","current":-7.230163,"twenty":-60.555129,"median":-18.461926,"eighty":-12.206067,"marketCap":80363259},{"date":"2022-01-14","current":-6.833643,"twenty":-60.555129,"median":-17.887117,"eighty":-11.984528,"marketCap":75955939},{"date":"2022-01-21","current":-5.419838,"twenty":-60.555129,"median":-17.727589,"eighty":-11.677476,"marketCap":60241499},{"date":"2022-01-28","current":-5.061958,"twenty":-60.555129,"median":-16.898705,"eighty":-11.301664,"marketCap":56263659},{"date":"2022-02-04","current":-5.483787,"twenty":-60.555129,"median":-16.175776,"eighty":-10.967575,"marketCap":60952297},{"date":"2022-02-11","current":-7.069867,"twenty":-60.555129,"median":-15.983021,"eighty":-10.387137,"marketCap":78581577},{"date":"2022-02-18","current":-6.81677,"twenty":-60.555129,"median":-15.647422,"eighty":-10.120541,"marketCap":75768394},{"date":"2022-02-25","current":-7.322965,"twenty":-60.555129,"median":-15.411038,"eighty":-9.418616,"marketCap":81394760},{"date":"2022-03-04","current":-7.13736,"twenty":-60.555129,"median":-15.198094,"eighty":-9.287005,"marketCap":79331759},{"date":"2022-03-11","current":-5.399421,"twenty":-60.555129,"median":-15.055489,"eighty":-7.731297,"marketCap":60014569},{"date":"2022-03-18","current":-3.748845,"twenty":-60.555129,"median":-14.955784,"eighty":-7.444452,"marketCap":54931819},{"date":"2022-03-25","current":-4.288062,"twenty":-60.555129,"median":-14.796256,"eighty":-7.302717,"marketCap":62832971},{"date":"2022-04-01","current":-4.416447,"twenty":-60.555129,"median":-14.626756,"eighty":-7.171106,"marketCap":64714198},{"date":"2022-04-08","current":-5.289466,"twenty":-60.555129,"median":-14.428142,"eighty":-7.076617,"marketCap":77506540},{"date":"2022-04-14","current":-4.4687,"twenty":-60.555129,"median":-14.426579,"eighty":-6.951755,"marketCap":65479857},{"date":"2022-04-22","current":-4.64754,"twenty":-60.555129,"median":-14.038496,"eighty":-6.889324,"marketCap":68100406},{"date":"2022-04-29","current":-3.081242,"twenty":-60.555129,"median":-13.958732,"eighty":-6.820145,"marketCap":45149440},{"date":"2022-05-06","current":-3.346101,"twenty":-60.555129,"median":-13.77786,"eighty":-6.48268,"marketCap":49030411},{"date":"2022-05-13","current":-2.840843,"twenty":-60.555129,"median":-13.659616,"eighty":-6.014858,"marketCap":52370949},{"date":"2022-05-20","current":-2.237931,"twenty":-60.555129,"median":-13.521562,"eighty":-5.632272,"marketCap":41256251},{"date":"2022-05-27","current":-2.411651,"twenty":-60.555129,"median":-13.380441,"eighty":-5.517534,"marketCap":44458791},{"date":"2022-06-03","current":-2.707998,"twenty":-60.555129,"median":-13.280736,"eighty":-5.419838,"marketCap":49921948},{"date":"2022-06-10","current":-2.452527,"twenty":-60.555129,"median":-13.051414,"eighty":-5.315055,"marketCap":45212330},{"date":"2022-06-17","current":-2.3299,"twenty":-60.555129,"median":-12.582799,"eighty":-5.161081,"marketCap":42951713},{"date":"2022-06-24","current":-2.483183,"twenty":-60.555129,"median":-12.363448,"eighty":-4.711057,"marketCap":45777484},{"date":"2022-07-01","current":-2.268587,"twenty":-60.555129,"median":-12.190881,"eighty":-4.552535,"marketCap":41821405},{"date":"2022-07-08","current":-2.499738,"twenty":-60.555129,"median":-12.131058,"eighty":-4.42415,"marketCap":46082667},{"date":"2022-07-15","current":-2.217493,"twenty":-60.555129,"median":-11.984369,"eighty":-4.339416,"marketCap":40879482},{"date":"2022-07-22","current":-2.457636,"twenty":-60.555129,"median":-11.64557,"eighty":-4.254681,"marketCap":45306522},{"date":"2022-07-29","current":-2.595591,"twenty":-60.555129,"median":-11.473771,"eighty":-4.172515,"marketCap":47849716},{"date":"2022-08-05","current":-2.452527,"twenty":-60.555129,"median":-11.170053,"eighty":-3.923449,"marketCap":45212330},{"date":"2022-08-12","current":-1.544548,"twenty":-60.555129,"median":-11.035068,"eighty":-3.402872,"marketCap":34851171},{"date":"2022-08-19","current":-1.998049,"twenty":-60.555129,"median":-10.75666,"eighty":-3.158273,"marketCap":45083968},{"date":"2022-08-26","current":-2.128356,"twenty":-60.555129,"median":-10.377013,"eighty":-2.846974,"marketCap":48024227},{"date":"2022-09-02","current":-2.617009,"twenty":-60.555129,"median":-10.284211,"eighty":-2.79112,"marketCap":59050198},{"date":"2022-09-09","current":-2.682163,"twenty":-60.555129,"median":-9.879254,"eighty":-2.656101,"marketCap":60520327},{"date":"2022-09-16","current":-2.725599,"twenty":-60.555129,"median":-9.398368,"eighty":-2.67239,"marketCap":61500414},{"date":"2022-09-23","current":-2.160933,"twenty":-60.555129,"median":-9.330876,"eighty":-2.636466,"marketCap":48759292},{"date":"2022-09-30","current":-2.19351,"twenty":-60.555129,"median":-7.947273,"eighty":-2.595591,"marketCap":49494357},{"date":"2022-10-07","current":-2.258664,"twenty":-60.555129,"median":-7.736358,"eighty":-2.505541,"marketCap":50964486},{"date":"2022-10-14","current":-2.182651,"twenty":-60.555129,"median":-7.474824,"eighty":-2.483183,"marketCap":49249335},{"date":"2022-10-21","current":-1.607126,"twenty":-60.555129,"median":-7.415767,"eighty":-2.467985,"marketCap":36263192},{"date":"2022-10-28","current":-2.008908,"twenty":-60.555129,"median":-7.322965,"eighty":-2.452568,"marketCap":45328990},{"date":"2022-11-04","current":-1.954613,"twenty":-60.555129,"median":-7.225945,"eighty":-2.452527,"marketCap":44103882},{"date":"2022-11-11","current":-1.576798,"twenty":-45.274461,"median":-7.13736,"eighty":-2.40552,"marketCap":41898688},{"date":"2022-11-18","current":-1.318609,"twenty":-22.35346,"median":-7.086741,"eighty":-2.353137,"marketCap":35038084},{"date":"2022-11-25","current":-1.493809,"twenty":-22.35346,"median":-7.044557,"eighty":-2.336787,"marketCap":39693494},{"date":"2022-12-02","current":-1.954861,"twenty":-22.35346,"median":-6.951755,"eighty":-2.319682,"marketCap":51944572},{"date":"2022-12-09","current":-2.176166,"twenty":-21.947033,"median":-6.91379,"eighty":-2.291069,"marketCap":57825090},{"date":"2022-12-16","current":-1.576798,"twenty":-20.321327,"median":-6.867389,"eighty":-2.277598,"marketCap":41898688},{"date":"2022-12-23","current":-1.632125,"twenty":-20.30507,"median":-6.825207,"eighty":-2.25851,"marketCap":43368817},{"date":"2022-12-30","current":-2.130061,"twenty":-20.240042,"median":-6.79146,"eighty":-2.249935,"marketCap":56599982},{"date":"2023-01-06","current":-2.609555,"twenty":-20.207528,"median":-6.500397,"eighty":-2.249578,"marketCap":69341104},{"date":"2023-01-13","current":-2.130061,"twenty":-20.101857,"median":-6.293701,"eighty":-2.248149,"marketCap":56599982},{"date":"2023-01-20","current":-2.139282,"twenty":-20.065278,"median":-6.008422,"eighty":-2.222649,"marketCap":56845004},{"date":"2023-01-27","current":-2.102398,"twenty":-20.044957,"median":-5.763894,"eighty":-2.196076,"marketCap":55864917},{"date":"2023-02-03","current":-2.231493,"twenty":-19.951479,"median":-5.568153,"eighty":-2.194169,"marketCap":59295219},{"date":"2023-02-10","current":-1.779661,"twenty":-19.833615,"median":-5.517534,"eighty":-2.176617,"marketCap":47289163},{"date":"2023-02-17","current":-1.800593,"twenty":-19.573503,"median":-5.483787,"eighty":-2.16454,"marketCap":47845361},{"date":"2023-02-24","current":-1.346272,"twenty":-19.25649,"median":-5.405012,"eighty":-2.156798,"marketCap":35773149},{"date":"2023-03-03","current":-1.456925,"twenty":-18.976055,"median":-5.348802,"eighty":-2.139282,"marketCap":38713408},{"date":"2023-03-10","current":-1.171073,"twenty":-18.760649,"median":-5.247563,"eighty":-2.137131,"marketCap":31117739},{"date":"2023-03-17","current":-1.078862,"twenty":-18.468022,"median":-5.111519,"eighty":-2.129038,"marketCap":28667523},{"date":"2023-03-24","current":-1.134188,"twenty":-18.28513,"median":-4.724571,"eighty":-2.11729,"marketCap":30137653},{"date":"2023-03-31","current":-1.116819,"twenty":-17.994243,"median":-4.628283,"eighty":-2.093853,"marketCap":31852804},{"date":"2023-04-06","current":-1.013728,"twenty":-17.857797,"median":-4.525575,"eighty":-2.054716,"marketCap":28912545},{"date":"2023-04-14","current":-1.108228,"twenty":-17.737933,"median":-4.429286,"eighty":-2.044514,"marketCap":31607782},{"date":"2023-04-21","current":-0.9793,"twenty":-17.711636,"median":-4.39077,"eighty":-2.024631,"marketCap":27930624},{"date":"2023-04-28","current":-1.600107,"twenty":-17.499729,"median":-4.3009,"eighty":-2.010187,"marketCap":45636646},{"date":"2023-05-05","current":-2.002319,"twenty":-16.903888,"median":-4.281643,"eighty":-2.008908,"marketCap":57108152},{"date":"2023-05-12","current":-1.906138,"twenty":-16.800043,"median":-4.223869,"eighty":-2.008908,"marketCap":54364966},{"date":"2023-05-19","current":-3.134129,"twenty":-16.387118,"median":-4.172515,"eighty":-2.008908,"marketCap":93713596},{"date":"2023-05-26","current":-2.576951,"twenty":-16.167082,"median":-4.031292,"eighty":-2.009164,"marketCap":77053401},{"date":"2023-06-02","current":-3.044583,"twenty":-16.132305,"median":-3.87723,"eighty":-2.010187,"marketCap":91036064},{"date":"2023-06-09","current":-2.397858,"twenty":-16.013206,"median":-3.466397,"eighty":-2.010187,"marketCap":71698338},{"date":"2023-06-16","current":-2.109319,"twenty":-15.952836,"median":-3.338012,"eighty":-2.010187,"marketCap":63070737},{"date":"2023-06-23","current":-1.910326,"twenty":-15.724762,"median":-3.218941,"eighty":-2.008908,"marketCap":57120668},{"date":"2023-06-30","current":-1.611838,"twenty":-15.65555,"median":-3.138239,"eighty":-2.001778,"marketCap":48195563},{"date":"2023-07-07","current":-1.661586,"twenty":-15.570177,"median":-3.134129,"eighty":-1.998049,"marketCap":49683081},{"date":"2023-07-14","current":-1.691435,"twenty":-15.437001,"median":-3.034633,"eighty":-1.966279,"marketCap":50575591},{"date":"2023-07-21","current":-1.591939,"twenty":-15.343021,"median":-2.997073,"eighty":-1.948098,"marketCap":47600556},{"date":"2023-07-28","current":-1.238727,"twenty":-15.240995,"median":-2.910292,"eighty":-1.927198,"marketCap":37039183},{"date":"2023-08-04","current":-1.263601,"twenty":-15.206675,"median":-2.86549,"eighty":-1.903019,"marketCap":37782941},{"date":"2023-08-11","current":-1.144206,"twenty":-15.147218,"median":-2.826657,"eighty":-1.879294,"marketCap":34212900},{"date":"2023-08-18","current":-1.183602,"twenty":-15.103347,"median":-2.765993,"eighty":-1.844935,"marketCap":36025305},{"date":"2023-08-25","current":-1.059013,"twenty":-15.015607,"median":-2.720922,"eighty":-1.788034,"marketCap":32233167},{"date":"2023-09-01","current":-1.09016,"twenty":-14.955784,"median":-2.706296,"eighty":-1.751998,"marketCap":33181202},{"date":"2023-09-08","current":-1.005128,"twenty":-14.955784,"median":-2.665875,"eighty":-1.734645,"marketCap":30593068},{"date":"2023-09-15","current":-0.975953,"twenty":-14.951862,"median":-2.637688,"eighty":-1.702114,"marketCap":29705076},{"date":"2023-09-22","current":-1.204367,"twenty":-14.908192,"median":-2.636466,"eighty":-1.688248,"marketCap":36657328},{"date":"2023-09-29","current":-1.152455,"twenty":-14.784291,"median":-2.613282,"eighty":-1.672875,"marketCap":35077270},{"date":"2023-10-06","current":-1.017587,"twenty":-14.720479,"median":-2.595591,"eighty":-1.660148,"marketCap":30972282},{"date":"2023-10-13","current":-0.986335,"twenty":-14.644703,"median":-2.581926,"eighty":-1.631815,"marketCap":30021087},{"date":"2023-10-20","current":-0.996718,"twenty":-14.592857,"median":-2.545008,"eighty":-1.604995,"marketCap":30337099},{"date":"2023-10-27","current":-1.038248,"twenty":-14.58488,"median":-2.535787,"eighty":-1.598161,"marketCap":31601145},{"date":"2023-11-03","current":-1.038248,"twenty":-14.487647,"median":-2.512992,"eighty":-1.579913,"marketCap":31601145},{"date":"2023-11-10","current":-1.04863,"twenty":-14.428142,"median":-2.508124,"eighty":-1.53388,"marketCap":31917156},{"date":"2023-11-17","current":-0.975284,"twenty":-14.427204,"median":-2.499738,"eighty":-1.499342,"marketCap":29460407},{"date":"2023-11-24","current":-0.773116,"twenty":-14.345588,"median":-2.483183,"eighty":-1.472685,"marketCap":23353524},{"date":"2023-12-01","current":-0.879023,"twenty":-14.181765,"median":-2.475843,"eighty":-1.42357,"marketCap":26552637},{"date":"2023-12-08","current":-1.045507,"twenty":-14.054449,"median":-2.460191,"eighty":-1.396066,"marketCap":31581643},{"date":"2023-12-15","current":-2.478208,"twenty":-13.958732,"median":-2.457636,"eighty":-1.392378,"marketCap":74859244},{"date":"2023-12-22","current":-1.846609,"twenty":-13.958732,"median":-2.452578,"eighty":-1.396066,"marketCap":55780526},{"date":"2023-12-29","current":-2.032702,"twenty":-13.958732,"median":-2.452527,"eighty":-1.401599,"marketCap":61401819},{"date":"2024-01-05","current":-1.989757,"twenty":-13.925599,"median":-2.452527,"eighty":-1.402377,"marketCap":60104598},{"date":"2024-01-12","current":-2.204479,"twenty":-13.852506,"median":-2.432089,"eighty":-1.40765,"marketCap":66590705},{"date":"2024-01-19","current":-2.063553,"twenty":-13.785989,"median":-2.419201,"eighty":-1.41082,"marketCap":62333748},{"date":"2024-01-26","current":-1.86293,"twenty":-13.736241,"median":-2.404062,"eighty":-1.42357,"marketCap":56273522},{"date":"2024-02-02","current":-1.719628,"twenty":-13.704713,"median":-2.380995,"eighty":-1.448386,"marketCap":51944790},{"date":"2024-02-09","current":-1.748288,"twenty":-13.628938,"median":-2.367158,"eighty":-1.456925,"marketCap":52810536},{"date":"2024-02-16","current":-1.576325,"twenty":-13.58292,"median":-2.350965,"eighty":-1.460613,"marketCap":47616057},{"date":"2024-02-23","current":-1.447353,"twenty":-13.558377,"median":-2.345229,"eighty":-1.458769,"marketCap":43720198},{"date":"2024-03-01","current":-1.590655,"twenty":-13.444252,"median":-2.3299,"eighty":-1.456925,"marketCap":48048930},{"date":"2024-03-08","current":-1.748288,"twenty":-13.380441,"median":-2.319682,"eighty":-1.458769,"marketCap":52810536},{"date":"2024-03-15","current":-1.662307,"twenty":-13.376453,"median":-2.304353,"eighty":-1.46812,"marketCap":50213297},{"date":"2024-03-22","current":-1.803218,"twenty":-13.344547,"median":-2.289025,"eighty":-1.47731,"marketCap":54109156},{"date":"2024-03-28","current":-1.745515,"twenty":-13.280736,"median":-2.278806,"eighty":-1.482493,"marketCap":52377663},{"date":"2024-04-05","current":-1.615683,"twenty":-13.260795,"median":-2.273092,"eighty":-1.493809,"marketCap":48481804},{"date":"2024-04-12","current":-1.65896,"twenty":-13.220913,"median":-2.258664,"eighty":-1.493809,"marketCap":49780423},{"date":"2024-04-19","current":-1.514703,"twenty":-12.881915,"median":-2.256631,"eighty":-1.482493,"marketCap":45451691},{"date":"2024-04-26","current":-1.500277,"twenty":-12.662564,"median":-2.248149,"eighty":-1.482493,"marketCap":45018818},{"date":"2024-05-03","current":-1.496325,"twenty":-12.582799,"median":-2.24304,"eighty":-1.482493,"marketCap":44900232},{"date":"2024-05-10","current":-1.432162,"twenty":-12.522976,"median":-2.231493,"eighty":-1.471426,"marketCap":44460034},{"date":"2024-05-17","current":-1.446342,"twenty":-12.363448,"median":-2.22179,"eighty":-1.466146,"marketCap":44900232},{"date":"2024-05-24","current":-1.47456,"twenty":-12.249186,"median":-2.21305,"eighty":-1.460522,"marketCap":45776227},{"date":"2024-05-31","current":-1.463976,"twenty":-12.22279,"median":-2.204479,"eighty":-1.456925,"marketCap":45447667},{"date":"2024-06-07","current":-1.606109,"twenty":-12.175695,"median":-2.195832,"eighty":-1.459803,"marketCap":49860062},{"date":"2024-06-14","current":-2.387844,"twenty":-12.164651,"median":-2.194059,"eighty":-1.462594,"marketCap":74128234},{"date":"2024-06-21","current":-1.307913,"twenty":-12.137654,"median":-2.185365,"eighty":-1.456925,"marketCap":40602857},{"date":"2024-06-28","current":-1.278207,"twenty":-12.111271,"median":-2.180423,"eighty":-1.456032,"marketCap":39680667},{"date":"2024-07-05","current":-1.134937,"twenty":-12.029972,"median":-2.177406,"eighty":-1.446342,"marketCap":35232973},{"date":"2024-07-12","current":-1.194064,"twenty":-11.984449,"median":-2.176166,"eighty":-1.442646,"marketCap":37068529},{"date":"2024-07-15","current":-1.247649,"twenty":-11.984409,"median":-2.173979,"eighty":-1.442545,"marketCap":38732002},{"date":"2024-08-02","current":-1.208135,"twenty":-11.984369,"median":-2.171792,"eighty":-1.44243,"marketCap":37505356},{"date":"2024-08-09","current":-0.972336,"twenty":-11.964627,"median":-2.163939,"eighty":-1.432162,"marketCap":30185193},{"date":"2024-08-16","current":-0.882654,"twenty":-11.805099,"median":-2.157724,"eighty":-1.410954,"marketCap":28207850},{"date":"2024-08-23","current":-0.761433,"twenty":-11.486042,"median":-2.153127,"eighty":-1.401599,"marketCap":24333891},{"date":"2024-08-30","current":-0.760116,"twenty":-11.473771,"median":-2.145961,"eighty":-1.383157,"marketCap":24291783},{"date":"2024-09-06","current":-0.49469,"twenty":-11.473771,"median":-2.139282,"eighty":-1.363657,"marketCap":15809309},{"date":"2024-09-13","current":-0.440961,"twenty":-11.406278,"median":-2.139215,"eighty":-1.340739,"marketCap":14092228},{"date":"2024-09-20","current":-0.470095,"twenty":-11.213923,"median":-2.135742,"eighty":-1.289457,"marketCap":15023289},{"date":"2024-09-27","current":-0.417244,"twenty":-11.170053,"median":-2.130061,"eighty":-1.276954,"marketCap":13334280},{"date":"2024-10-04","current":-0.3865,"twenty":-11.143056,"median":-2.126474,"eighty":-1.252451,"marketCap":12351754},{"date":"2024-10-11","current":-0.336577,"twenty":-11.055316,"median":-2.117497,"eighty":-1.235515,"marketCap":10756319},{"date":"2024-10-18","current":-0.33687,"twenty":-10.900082,"median":-2.109319,"eighty":-1.21758,"marketCap":10765676},{"date":"2024-10-25","current":-0.468631,"twenty":-10.812342,"median":-2.095323,"eighty":-1.203755,"marketCap":14976502},{"date":"2024-10-31","current":-0.39543,"twenty":-10.748223,"median":-2.092695,"eighty":-1.194032,"marketCap":12637154},{"date":"2024-11-08","current":-0.484003,"twenty":-10.522122,"median":-2.089364,"eighty":-1.182279,"marketCap":15467765},{"date":"2024-11-15","current":-0.493189,"twenty":-10.383762,"median":-2.069928,"eighty":-1.172361,"marketCap":15720414},{"date":"2024-11-22","current":-0.727675,"twenty":-10.366889,"median":-2.063526,"eighty":-1.163203,"marketCap":23194640},{"date":"2024-11-29","current":-0.692883,"twenty":-10.333143,"median":-2.052343,"eighty":-1.153748,"marketCap":22085647},{"date":"2024-12-06","current":-0.682195,"twenty":-10.285898,"median":-2.047072,"eighty":-1.146883,"marketCap":21744975},{"date":"2024-12-13","current":-0.66082,"twenty":-10.120541,"median":-2.043874,"eighty":-1.13907,"marketCap":21063633},{"date":"2024-12-20","current":-0.546666,"twenty":-9.880941,"median":-2.034998,"eighty":-1.134188,"marketCap":17424974},{"date":"2024-12-27","current":-0.578502,"twenty":-9.786451,"median":-2.03022,"eighty":-1.134038,"marketCap":18439739},{"date":"2025-01-03","current":-0.63717,"twenty":-9.448987,"median":-2.021551,"eighty":-1.122855,"marketCap":20309807},{"date":"2025-01-10","current":-0.710847,"twenty":-9.408492,"median":-2.010187,"eighty":-1.116819,"marketCap":22658264},{"date":"2025-01-17","current":-0.674464,"twenty":-9.371371,"median":-2.008908,"eighty":-1.107887,"marketCap":21498532},{"date":"2025-01-24","current":-0.652179,"twenty":-9.364622,"median":-2.004072,"eighty":-1.101073,"marketCap":20788196},{"date":"2025-01-31","current":-0.563721,"twenty":-9.324126,"median":-2.001642,"eighty":-1.097961,"marketCap":17968598},{"date":"2025-02-07","current":-0.629894,"twenty":-9.287005,"median":-1.998049,"eighty":-1.084711,"marketCap":20077861},{"date":"2025-02-14","current":-0.734724,"twenty":-8.480466,"median":-1.989757,"eighty":-1.079412,"marketCap":23419339},{"date":"2025-02-21","current":-0.65036,"twenty":-7.873031,"median":-1.984857,"eighty":-1.069395,"marketCap":20730210},{"date":"2025-02-28","current":-0.576228,"twenty":-7.761668,"median":-1.963783,"eighty":-1.052376,"marketCap":18367256},{"date":"2025-03-07","current":-0.58828,"twenty":-7.74142,"median":-1.954613,"eighty":-1.046541,"marketCap":18751417},{"date":"2025-03-14","current":-0.514603,"twenty":-7.684052,"median":-1.94723,"eighty":-1.038248,"marketCap":16402960},{"date":"2025-03-21","current":-0.621782,"twenty":-7.576063,"median":-1.937378,"eighty":-1.029162,"marketCap":18925165},{"date":"2025-03-28","current":-0.555572,"twenty":-7.474824,"median":-1.932498,"eighty":-1.018376,"marketCap":16909948},{"date":"2025-04-04","current":-0.430361,"twenty":-7.454576,"median":-1.923725,"eighty":-1.015188,"marketCap":13098912},{"date":"2025-04-11","current":-0.392718,"twenty":-7.417455,"median":-1.910326,"eighty":-1.00529,"marketCap":11953164},{"date":"2025-04-17","current":-0.42075,"twenty":-7.400582,"median":-1.906138,"eighty":-0.992946,"marketCap":12806381},{"date":"2025-04-25","current":-0.493901,"twenty":-7.363461,"median":-1.902764,"eighty":-0.983856,"marketCap":15032871},{"date":"2025-05-02","current":-0.453588,"twenty":-7.316216,"median":-1.899535,"eighty":-0.976534,"marketCap":13805863},{"date":"2025-05-09","current":-0.497478,"twenty":-7.277408,"median":-1.883407,"eighty":-0.972926,"marketCap":13643346},{"date":"2025-05-16","current":-0.438552,"twenty":-7.228476,"median":-1.871872,"eighty":-0.963991,"marketCap":12027282},{"date":"2025-05-23","current":-0.439545,"twenty":-7.221726,"median":-1.86293,"eighty":-0.937651,"marketCap":12054514},{"date":"2025-05-30","current":-0.507727,"twenty":-7.221726,"median":-1.86244,"eighty":-0.918094,"marketCap":13924416},{"date":"2025-06-06","current":-0.452491,"twenty":-7.13736,"median":-1.85343,"eighty":-0.881988,"marketCap":12409571},{"date":"2025-06-13","current":-0.298898,"twenty":-7.120487,"median":-1.846259,"eighty":-0.836826,"marketCap":8197267},{"date":"2025-06-20","current":-0.267501,"twenty":-7.09349,"median":-1.844209,"eighty":-0.789983,"marketCap":7336209},{"date":"2025-06-27","current":-0.271268,"twenty":-7.086741,"median":-1.819939,"eighty":-0.773116,"marketCap":7439536},{"date":"2025-07-03","current":-0.27378,"twenty":-7.076617,"median":-1.803218,"eighty":-0.769837,"marketCap":7508421},{"date":"2025-07-11","current":-0.287595,"twenty":-7.039496,"median":-1.795936,"eighty":-0.758828,"marketCap":7887286},{"date":"2025-07-18","current":-0.276292,"twenty":-6.978752,"median":-1.788792,"eighty":-0.734997,"marketCap":7577306},{"date":"2025-07-25","current":-0.302665,"twenty":-6.951755,"median":-1.776194,"eighty":-0.730523,"marketCap":8300594},{"date":"2025-08-01","current":-0.267501,"twenty":-6.941631,"median":-1.775035,"eighty":-0.721671,"marketCap":7336209},{"date":"2025-08-08","current":-0.270013,"twenty":-6.924758,"median":-1.766314,"eighty":-0.708482,"marketCap":7405094},{"date":"2025-08-15","current":-0.456062,"twenty":-6.912947,"median":-1.751998,"eighty":-0.69467,"marketCap":10895320},{"date":"2025-08-22","current":-0.425658,"twenty":-6.894386,"median":-1.74829,"eighty":-0.690108,"marketCap":10168966},{"date":"2025-08-29","current":-0.429458,"twenty":-6.874138,"median":-1.748288,"eighty":-0.678245,"marketCap":10259760},{"date":"2025-09-05","current":-0.414256,"twenty":-6.853891,"median":-1.745515,"eighty":-0.665277,"marketCap":9896583},{"date":"2025-09-12","current":-0.397154,"twenty":-6.833643,"median":-1.732763,"eighty":-0.657272,"marketCap":9488008},{"date":"2025-09-19","current":-0.391453,"twenty":-6.826894,"median":-1.731089,"eighty":-0.65036,"marketCap":9351817},{"date":"2025-09-26","current":-0.397154,"twenty":-6.81677,"median":-1.722809,"eighty":-0.632804,"marketCap":9488008},{"date":"2025-10-03","current":-0.435159,"twenty":-6.796522,"median":-1.719628,"eighty":-0.622116,"marketCap":10395951},{"date":"2025-10-10","current":-0.44276,"twenty":-6.67166,"median":-1.703635,"eighty":-0.615477,"marketCap":10577540},{"date":"2025-10-17","current":-0.400954,"twenty":-6.506303,"median":-1.696672,"eighty":-0.61102,"marketCap":9578802},{"date":"2025-10-24","current":-0.399054,"twenty":-6.4135,"median":-1.691412,"eighty":-0.608649,"marketCap":9533405},{"date":"2025-10-31","current":-0.378151,"twenty":-6.313949,"median":-1.683139,"eighty":-0.604743,"marketCap":9034036},{"date":"2025-11-07","current":-0.315443,"twenty":-6.192462,"median":-1.674883,"eighty":-0.589735,"marketCap":7535930},{"date":"2025-11-14","current":-0.367916,"twenty":-5.748368,"median":-1.661586,"eighty":-0.581385,"marketCap":7600409},{"date":"2025-11-21","current":-0.356699,"twenty":-5.517534,"median":-1.651636,"eighty":-0.574045,"marketCap":7368689},{"date":"2025-11-28","current":-0.444191,"twenty":-5.410942,"median":-1.632125,"eighty":-0.562811,"marketCap":9176104},{"date":"2025-12-05","current":-0.408297,"twenty":-5.264324,"median":-1.607126,"eighty":-0.54994,"marketCap":8434600},{"date":"2025-12-12","current":-0.388107,"twenty":-4.859526,"median":-1.601257,"eighty":-0.523633,"marketCap":8017505},{"date":"2025-12-19","current":-0.309588,"twenty":-4.516588,"median":-1.590655,"eighty":-0.504443,"marketCap":6395466},{"date":"2025-12-26","current":-0.448678,"twenty":-4.408744,"median":-1.586832,"eighty":-0.493616,"marketCap":9268792},{"date":"2026-01-02","current":-0.524953,"twenty":-4.3009,"median":-1.576798,"eighty":-0.492778,"marketCap":10844486},{"date":"2026-01-09","current":-0.538414,"twenty":-4.20076,"median":-1.549256,"eighty":-0.492778,"marketCap":11122550},{"date":"2026-01-16","current":-0.520467,"twenty":-3.985073,"median":-1.525665,"eighty":-0.489933,"marketCap":10751798},{"date":"2026-01-23","current":-1.172427,"twenty":-3.461262,"median":-1.514703,"eighty":-0.489933,"marketCap":24220007},{"date":"2026-01-30","current":-0.945506,"twenty":-3.213353,"median":-1.500277,"eighty":-0.489933,"marketCap":19532264},{"date":"2026-02-06","current":-0.898231,"twenty":-3.059247,"median":-1.493809,"eighty":-0.489933,"marketCap":18555650},{"date":"2026-02-13","current":-0.874593,"twenty":-2.940606,"median":-1.482493,"eighty":-0.489933,"marketCap":18067344},{"date":"2026-02-20","current":-0.756405,"twenty":-2.856833,"median":-1.474701,"eighty":-0.489933,"marketCap":15625811},{"date":"2026-02-27","current":-0.808408,"twenty":-2.761853,"median":-1.464198,"eighty":-0.489933,"marketCap":16700085},{"date":"2026-03-06","current":-0.82259,"twenty":-2.706977,"median":-1.452462,"eighty":-0.489933,"marketCap":16993069},{"date":"2026-03-13","current":-0.902958,"twenty":-2.643071,"median":-1.446342,"eighty":-0.490225,"marketCap":18653312},{"date":"2026-03-20","current":-0.871244,"twenty":-2.637064,"median":-1.442574,"eighty":-0.491833,"marketCap":16936993},{"date":"2026-03-27","current":-0.74461,"twenty":-2.636502,"median":-1.432162,"eighty":-0.492984,"marketCap":14475220},{"date":"2026-04-02","current":-0.709152,"twenty":-2.636466,"median":-1.432162,"eighty":-0.493616,"marketCap":13785924},{"date":"2026-04-10","current":-0.724349,"twenty":-2.628462,"median":-1.421336,"eighty":-0.494374,"marketCap":14081337},{"date":"2026-04-17","current":-0.734479,"twenty":-2.619456,"median":-1.410887,"eighty":-0.495349,"marketCap":14278279},{"date":"2026-04-24","current":-0.719283,"twenty":-2.612537,"median":-1.402896,"eighty":-0.496802,"marketCap":13982866},{"date":"2026-05-01","current":-0.74461,"twenty":-2.601177,"median":-1.392378,"eighty":-0.499157,"marketCap":14475220},{"date":"2026-05-08","current":-0.81046,"twenty":-2.595591,"median":-1.383157,"eighty":-0.501931,"marketCap":15755342},{"date":"2026-05-15","current":-0.824914,"twenty":-2.595591,"median":-1.369803,"eighty":-0.504443,"marketCap":15656871},{"date":"2026-05-22","current":-0.871607,"twenty":-2.590376,"median":-1.355493,"eighty":-0.506789,"marketCap":16543109},{"date":"2026-05-29","current":-0.933865,"twenty":-2.58292,"median":-1.346272,"eighty":-0.509539,"marketCap":17724760},{"date":"2026-06-05","current":-0.798973,"twenty":-2.565011,"median":-1.305656,"eighty":-0.513196,"marketCap":15164517},{"date":"2026-06-12","current":-0.747092,"twenty":-2.546264,"median":-1.2835,"eighty":-0.516949,"marketCap":14179808},{"date":"2026-06-18","current":-0.762656,"twenty":-2.543164,"median":-1.278207,"eighty":-0.520916,"marketCap":14475220},{"date":"2026-06-26","current":-0.705587,"twenty":-2.532485,"median":-1.270094,"eighty":-0.522875,"marketCap":13392041},{"date":"2026-07-02","current":-0.736716,"twenty":-2.519279,"median":-1.258468,"eighty":-0.523535,"marketCap":13982866},{"date":"2026-07-10","current":-0.72634,"twenty":-2.517253,"median":-1.244841,"eighty":-0.523699,"marketCap":13785924},{"date":"2026-07-17","current":-0.715963,"twenty":-2.50873,"median":-1.235515,"eighty":-0.524953,"marketCap":13588982},{"date":"2026-07-24","current":-0.617389,"twenty":-2.50842,"median":-1.223202,"eighty":-0.527197,"marketCap":11718035},{"date":"2026-07-31","current":-0.560319,"twenty":-2.486494,"median":-1.204136,"eighty":-0.526748,"marketCap":10634856},{"date":"2026-08-07","current":-0.503198,"twenty":-2.475843,"median":-1.193985,"eighty":-0.522261,"marketCap":9550691},{"date":"2026-08-14","current":-0.623179,"twenty":-2.452547,"median":-1.173637,"eighty":-0.515939,"marketCap":11632891},{"date":"2026-08-21","current":-0.639023,"twenty":-2.436177,"median":-1.166577,"eighty":-0.515939,"marketCap":11928643}],"updateTime":1787446633356},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INAB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658947762","title":"Mizuho Securities Reaffirms Their Buy Rating on IN8bio (INAB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658947762","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658947762?lang=en_us&edition=fundamental","pubTime":"2026-08-12 09:55","pubTimestamp":1786499716,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Uy Ear maintained a Buy rating on IN8bio yesterday and set a price target of $4.00. According to TipRanks, Ear is a 4-sta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-reaffirms-their-buy-rating-on-in8bio-inab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-reaffirms-their-buy-rating-on-in8bio-inab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INAB","MFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956446","title":"IN8bio Grants New Hire Stock Option for 4,000 Shares Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956446","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956446?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:02","pubTimestamp":1786392132,"startTime":"0","endTime":"0","summary":"IN8bio grants new hire stock option for 4,000 shares under inducement planIN8bio granted a nonqualified stock option covering 4,000 common shares under its 2026 Inducement Plan, with a grant date of A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL2BlNVl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","IE00BGHQF748.EUR","NDAQ","LU2210149790.SGD","IE00BKPKM429.USD","BK4139","BK4539","LU2095319765.USD","SG9999014021.USD","SG9999014039.USD","BCDF","IE00B64PRP62.GBP","SG9999014005.SGD","BK4112","SG9999014013.SGD","LU2210150020.SGD","BK4585","BK4588","LU0314104364.USD","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","INAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956132","title":"IN8bio Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956132","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956132?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:01","pubTimestamp":1786392060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA6NTR6F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","INAB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658952560","title":"IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658952560","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658952560?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:01","pubTimestamp":1786392060,"startTime":"0","endTime":"0","summary":"NEW YORK, Aug.  10, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (the “Company”) (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/10/3342180/0/en/in8bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB","BK4539","LCLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657864294","title":"Analysts Offer Insights on Healthcare Companies: IN8bio (INAB), Lineage Therap (LCTX) and BioLife Solutions (BLFS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657864294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657864294?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:00","pubTimestamp":1786114839,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on IN8bio (INAB), Lineage Therap (LCTX) and BioLife S...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-in8bio-inab-lineage-therap-lctx-and-biolife-solutions-blfs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-in8bio-inab-lineage-therap-lctx-and-biolife-solutions-blfs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCTX","LU1169589451.USD","INAB","XBI","BK4588","BK4137","BK4121","LABU","LU0029874061.USD","BK4139","BK4539","LU0128526141.USD","HCSG","BK4198","LU1169590202.USD","XLV","BLFS","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657266986","title":"IN8bio Q2 EPS $(0.25) Beats $(0.37) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657266986","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657266986?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:58","pubTimestamp":1786053516,"startTime":"0","endTime":"0","summary":"IN8bio (NASDAQ:INAB) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.37) by 32.43 percent. This is a 79.84 percent increase over losses of $(1.24) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61026442/in8bio-q2-eps-0-25-beats-0-37-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"IN8bio Q2 EPS $(0.25) Beats $(0.37) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657665242","title":"IN8bio, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657665242","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657665242?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:20","pubTimestamp":1786051233,"startTime":"0","endTime":"0","summary":"IN8bio, Inc. reports results for the quarter ended June 30 - Earnings SummaryIN8bio, Inc.INAB.OQreported a quarterly adjusted loss of 25 cents per share for the quarter ended June 30, higher than the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4433FE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650667","title":"Biopharma Firm IN8bio's Q2 Net Loss Narrows as Expenses Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650667","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650667?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:16","pubTimestamp":1786047402,"startTime":"0","endTime":"0","summary":"Biopharma firm IN8bio's Q2 net loss narrows as expenses declineOverviewUS biopharma firm's Q2 net loss narrowed yr/yr, with flat R&D and lower G&A expensesCompany reported updated clinical data showin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALXO","CGON","BK4539","SBIO","INAB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657565221","title":"Press Release: IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2657565221","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657565221?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:01","pubTimestamp":1786046460,"startTime":"0","endTime":"0","summary":"-- Advanced next-generation gamma delta  T cell engager . platform demonstrating a novel mechanism for <GAMMA> T cell expansion,deep target cell depletion, and favorable cytokine profile; Initial in. -- Presented updated data at ASCO 2026 demonstrating median overall survival.  exceeding 19.5 months and still climbing, across all patients with. -- Reported new translational AI proteomic and immunogenomic analyses. demonstrating DeltEx DRI preserves immune function and positively. and infections, while expanding the therapeutic window compared with. -- Advancing INB-619, a CD19-targeting <GAMMA> T cell engager for oncology. and autoimmune diseases, into IND-enabling studies following encouraging. early preclinical data demonstrating complete B cell depletion, robust","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4187","TM","LU2065731478.USD","INAB","SOC","IE00B7SZL793.SGD","BK4555","BK4539","03160","BK4006","BK4213","IE0031619046.USD","BK4099","BK4585","LU0154245756.USD","BK4139","BK4209","PYZ","BK4604","BK4588","IE00B66KJ199.SGD","IE00B19Z4B17.USD","SBC","BK4196","DRI","BK4504","XAR","LU0154245673.USD","CRS","LU0963586101.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656376884","title":"IN8bio Inc Expected to Post a Loss of 37 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656376884","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656376884?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:47","pubTimestamp":1785757625,"startTime":"0","endTime":"0","summary":"IN8bio Inc <INAB.OQ> expected to post a loss of37cents a share - Earnings PreviewIN8bio IncINAB.OQINAB.Ois expected to  show no change in quarterly revenue when it reports  results on August 5 (estima","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N44012F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650376927","title":"IN8bio therapy doubles progression free survival in brain cancer trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2650376927","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650376927?lang=en_us&edition=fundamental","pubTime":"2026-07-09 21:35","pubTimestamp":1783604120,"startTime":"0","endTime":"0","summary":"IN8bio (INAB) announced the publication of peer-reviewed clinical data from its Phase 1 trial of INB-200 in The Journal of Clinical Oncology. “Thes...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/in8bio-therapy-doubles-progression-free-survival-in-brain-cancer-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/in8bio-therapy-doubles-progression-free-survival-in-brain-cancer-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INAB","BK4539","BK4139","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650921841","title":"In8bio Says JCO Publication Shows Inb-200 Trial Doubles Progression-free Survival in Repeat-dose Glioblastoma Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2650921841","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650921841?lang=en_us&edition=fundamental","pubTime":"2026-07-09 20:03","pubTimestamp":1783598584,"startTime":"0","endTime":"0","summary":"IN8bio says JCO publication shows INB-200 trial doubles progression-free survival in repeat-dose glioblastoma patientsIN8bio disclosed peer-reviewed Phase 1 data for INB-200 in newly diagnosed gliobla","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL2zTS7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IE00B3QW5Z07.USD","BCDF","BK4112","SG9999014039.USD","BK4585","BK4139","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2095319765.USD","BK4588","INAB","IE00BN0W2W23.USD","SG9999014013.SGD","SG9999014005.SGD","NDAQ","IE00BN0W2V16.EUR","LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014021.USD","LU0314104364.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650921338","title":"IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2650921338","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650921338?lang=en_us&edition=fundamental","pubTime":"2026-07-09 20:00","pubTimestamp":1783598400,"startTime":"0","endTime":"0","summary":"First peer-reviewed publication of chemotherapy-resistant gamma-delta T cells (DeltEx Drug Resistant Immunotherapy or DRI) clinical results in newly diagnosed glioblastoma Repeat-dose patients achieve","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/09/3324728/0/en/IN8bio-Announces-Publication-in-The-Journal-of-Clinical-Oncology-Demonstrating-DeltEx-DRI-Doubles-Progression-Free-Survival-in-Newly-Diagnosed-Glioblastoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRI","INAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649641756","title":"Analysts Are Bullish on Top Healthcare Stocks: Corvus Pharmaceuticals (CRVS), IN8bio (INAB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649641756","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649641756?lang=en_us&edition=fundamental","pubTime":"2026-07-06 15:30","pubTimestamp":1783323010,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Corvus Pharmaceuticals (CRVS), IN8bio (INAB) and Ver...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-corvus-pharmaceuticals-crvs-in8bio-inab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-corvus-pharmaceuticals-crvs-in8bio-inab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","CRVS","INAB","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640904693","title":"IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2640904693","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640904693?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:30","pubTimestamp":1780489800,"startTime":"0","endTime":"0","summary":"Review Highlights Emerging Engineering Strategies Including Combination Approaches Designed to Enhance Anti-Tumor Activity, Gamma-Delta T cell Engagers, CAR-Gamma-Delta T Cells and Cytokine-Armored Ce","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/03/3306028/0/en/IN8bio-Announces-Publication-in-Nature-Communications-Highlighting-Advances-in-Gamma-Delta-T-Cell-Engineering-and-Combination-Therapies.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","INAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640950110","title":"IN8bio posts corporate deck highlighting gamma-delta T-cell therapy platform for autoimmune disease, cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640950110","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640950110?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:35","pubTimestamp":1780324535,"startTime":"0","endTime":"0","summary":"IN8bio outlined a gamma-delta T cell platform spanning autoimmune disease and oncology, highlighting no serious side effects observed to date.Pipeline focus includes T cell engagers, with IND-enabling studies supported by initial mouse-model data expected in 2026.Cell therapy program in AML targets completion of dosing in an additional DL2 expansion cohort in 2026, with updates and follow-up by year-end 2026.First-line glioblastoma program is completed, with a peer-reviewed publication planned and FDA discussions on potential registrational paths targeted in 2026.Presentation flagged mid- and late-2026 updates for overall survival data in glioblastoma.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IN8BIO Inc. published the original co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLbBBGCF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","INAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640950385","title":"IN8bio announces updated INB-200, INB-400 study data","url":"https://stock-news.laohu8.com/highlight/detail?id=2640950385","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640950385?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:11","pubTimestamp":1780323118,"startTime":"0","endTime":"0","summary":"IN8bio (INAB) announced updated clinical data from its INB-200 Phase 1 and INB-400 Phase 2 studies at the 2026 American Society of Clinical Oncolog...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/in8bio-announces-updated-inb-200-inb-400-study-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/in8bio-announces-updated-inb-200-inb-400-study-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INAB","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640895146","title":"IN8bio says DeltEx DRI glioblastoma trial shows median overall survival exceeds 19.5 months at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640895146","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640895146?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:31","pubTimestamp":1780317086,"startTime":"0","endTime":"0","summary":"IN8bio presented updated survival results for its DeltEx DRI gamma-delta T cell therapy in newly diagnosed glioblastoma at ASCO 2026.Patients receiving repeat dosing with standard treatment showed longer disease control and survival than a contemporaneous standard-of-care comparison group.A meaningful share of treated patients remained alive at two years, outpacing the standard-of-care cohort.Safety profile remained supportive, with no major immune-related or neurologic safety signals reported in the studies.Immune and tissue analyses pointed to stronger anti-tumor immune activity, supporting a potential competitive differentiation in a long-stagnant treatment setting.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL7dL153:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BK4112","SG9999014039.USD","IE00BN0W2V16.EUR","BK4139","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014005.SGD","LU2095319765.USD","SG9999014013.SGD","LU2210150020.SGD","BK4539","INAB","SG9999014021.USD","IE00BKPKM429.USD","LU0314104364.USD","IE00BGHQF748.EUR","NDAQ","BK4585","BK4588","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640862956","title":"BRIEF-IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2640862956","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640862956?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:14","pubTimestamp":1780312486,"startTime":"0","endTime":"0","summary":"BRIEF-IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering June 1 (Reuters) - IN8bio Inc INAB.O:IN8BIO - ENTERS CAPITAL ON DEMAND SALES AGREEMENT WITH JONESTRADING FOR ATM OFFERING - SEC FILINGFurther company coverage: INAB.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN42802O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INAB","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640555439","title":"IN8bio - Enters Capital on Demand Sales Agreement With Jonestrading for Atm Offering - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640555439","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640555439?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:58","pubTimestamp":1780311523,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN42802O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INAB","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":46,"code":"91000000","status":"200"}]}}